The purpose of the treatment for metastatic breast cancer is to prolong the survival period and improve the cancer patients’ quality of life (QOL) by managing cancer-related symptoms. To that end, not the same strategy for all patients but individual approach for each patient should be used....
This study further explored patient-reported health-related quality of life (HRQOL), functioning, symptoms, and symptom tolerability in CAPItello-291. This phase 3, randomised, double-blind, placebo-controlled trial, which was conducted across 193 hospitals and cancer centres in 19 countries, ...
Caitlin Lewis, Senior Vice President of Strategy & Mission, Living Beyond Breast Cancer, said: “Only one in three patients with metastatic HR-positive, HER2-negative breast cancer live more than five years following diagnosis, highlighting the urgent need for additional effective therapies. The appr...
“We are thrilled by the approval of the Itovebi-based regimen, which is a huge step forward for advanced breast cancer patients with aPIK3CAmutation,” said Jean Sachs, CEO of Living Beyond Breast Cancer. “It remains critical that all patients have access to early, comprehensive biomarker t...
Metastatic breast cancer (MBC) remains incurable in most patients; the goals of treatment are to optimize quality of life, manage symptoms and prolong survival. A wide array of agents is available for the treatment of MBC, including endocrine therapies, cytotoxic chemotherapy (Table 1) and targete...
Abbreviations AC, doxorubicin and cyclophosphamide; AML, acute myeloid leukaemia; ATS, acute transition symptoms; BCSS, breast cancer specific survival; CEA, cost effectiveness analysis; CEAC, cost-effectiveness acceptability curves; CHEERS, Consolidated Health Economic Evaluation Reporting Standards; CHF, ...
[2]. Hence, there is an urgent need to develop metastatic breast cancer treatment that prolongs patient’s survival, alleviates symptoms, and improves the quality of life (QoL) [3]. Currently, the Japanese Breast Cancer Society recommends anthracyclines, taxanes, and S-1 as the first-line ...
In the case of advanced disease where two other drugs have been tried, the antibody-drug conjugatesacituzumab govitecan(Trodelvy) may be tried. Get an overview ontriple-negative breast cancer symptoms and treatment.
HER2, human epidermal growth factor receptor 2; HR, hormone receptor; IV, intravenous; mBC, metastatic breast cancer; Pts, patients; TNBC, triple-negative breast cancer. The Institutional Review Board of each investigational site approved the study before its initiation, and all patients provided wr...
Monitor patients for hyperglycemia or other signs and symptoms of diabetes. Initiate treatment with insulin as clinically indicated. Withhold KEYTRUDA depending on severity. Type 1 DM occurred in 0.2% (6/279...